SCHEMBL20330039

SCHEMBL20330039

Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NN)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 11/20 0.82
JAK2 O60674 10/20 0.82
JAK3 P52333 9/20 0.82
JAK1 P23458 8/20 0.82
TYK2 P29597 4/20 0.82
RET P07949 4/20 0.82
FLT3 P36888 4/20 0.82
BRDT Q58F21 3/20 0.82
WEE1 P30291 3/20 0.82
ALK Q9UM73 3/20 0.82
AXL P30530 3/20 0.82
ABL1 P00519 3/20 0.82
EGFR P00533 3/20 0.82
LCK P06239 3/20 0.82
FYN P06241 3/20 0.82
LYN P07948 3/20 0.82
FGFR1 P11362 3/20 0.82
SRC P12931 3/20 0.82
RPS6KB1 P23443 3/20 0.82
KDR P35968 3/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16985210 0.93 BRD4 (0.84) BRD4JAK2JAK3JAK1TYK2
SCHEMBL264158 0.92 JAK3 (0.79) BRD4JAK2JAK3JAK1TYK2
SCHEMBL30381504 0.92 JAK3 (0.79) BRD4JAK2JAK3JAK1TYK2
SCHEMBL20285974 0.91 JAK2 (0.81) BRD4JAK2JAK3JAK1TYK2
SCHEMBL28489539 0.91 BRD4 (0.81) BRD4JAK2JAK3JAK1TYK2
Fedratinib SCHEMBL263741 0.90 BRD4 (1.00) BRD4JAK2JAK3JAK1TYK2
Fedratinib SCHEMBL29351417 0.90 BRD4 (1.00) BRD4JAK2JAK3JAK1TYK2
Fedratinib SCHEMBL2734027 0.90 BRD4 (0.98) BRD4JAK2JAK3JAK1TYK2
SCHEMBL13868200 0.90 BRD4 (0.79) BRD4JAK2JAK3JAK1TYK2
Fedratinib SCHEMBL21773035 0.89 BRD4 (0.91) BRD4JAK2JAK3JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019173224-A1 DEUTERATED COMPOUNDS AND CHIMERAS AND USES THEREOF BIOTHERYX, INC. (US) 2019-09-12 WO disclosed
WO-2019040274-A1 ETHER COMPOUNDS AND USES THEREOF BIOTHERYX, INC. (US) 2019-02-28 WO disclosed
WO-2018118947-A1 THIENOPYRROLE DERIVATIVES FOR USE IN TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF BIOTHERYX, INC. (US) 2018-06-28 WO disclosed